Edmond de Rothschild Holding’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-154,160
| Closed | -$8.24M | – | 720 |
|
|
2020
Q4 | $8.24M | Hold |
154,160
| – | – | 0.28% | 104 |
|
|
2020
Q3 | $6.36M | Buy |
154,160
+33,500
| +28% | +$1.38M | 0.25% | 104 |
|
|
2020
Q2 | $5.85M | Hold |
120,660
| – | – | 0.24% | 116 |
|
|
2020
Q1 | $5.1M | Buy |
120,660
+48,560
| +67% | +$2.05M | 0.27% | 107 |
|
|
2019
Q4 | $3.08M | Sell |
72,100
-33,900
| -32% | -$1.45M | 0.12% | 146 |
|
|
2019
Q3 | $3.82M | Sell |
106,000
-194,300
| -65% | -$6.99M | 0.15% | 131 |
|
|
2019
Q2 | $8.03M | Sell |
300,300
-81,700
| -21% | -$2.18M | 0.3% | 84 |
|
|
2019
Q1 | $10.3M | Sell |
382,000
-30,000
| -7% | -$806K | 0.35% | 74 |
|
|
2018
Q4 | $6.66M | Buy |
412,000
+2,000
| +0.5% | +$32.3K | 0.23% | 92 |
|
|
2018
Q3 | $8.51M | Buy |
410,000
+40,548
| +11% | +$842K | 0.24% | 90 |
|
|
2018
Q2 | $5.64M | Buy |
369,452
+29,452
| +9% | +$450K | 0.16% | 124 |
|
|
2018
Q1 | $7.64M | Hold |
340,000
| – | – | 0.22% | 103 |
|
|
2017
Q4 | $10.2M | Sell |
340,000
-125,000
| -27% | -$3.76M | 0.29% | 87 |
|
|
2017
Q3 | $17.5M | Sell |
465,000
-10,000
| -2% | -$377K | 0.5% | 63 |
|
|
2017
Q2 | $13.2M | Buy |
475,000
+158,620
| +50% | +$4.42M | 0.37% | 72 |
|
|
2017
Q1 | $10.9M | Buy |
316,380
+216,380
| +216% | +$7.44M | 0.29% | 82 |
|
|
2016
Q4 | $2.88M | Buy |
+100,000
| New | +$2.88M | 0.08% | 166 |
|